At 33, retired Constitutional Court justice Edwin Cameron thought he had, maybe, seven years left. His story traces the arc ...

The tobacco industry is getting ready for the final showdown as South Africa’s Tobacco Bill heads into its last rounds, pulling out its well-worn talking points on illicit trade and high taxes. We ...

A review of 37 studies found that when people stop taking weight-loss drugs like Ozempic, the weight comes back. Experts working in obesity aren’t surprised because, they say, just like type 2 ...

After a year of US funding cuts across global public health, including South Africa’s hard-hit HIV programmes, new realities ...

Many mothers who work as domestic workers have to make an impossible choice: keep your job or breastfeed your child. It’s a ...

In today’s newsletter, Tanya Pampalone shares what experts have to say about some of the most pressing health issues this year. Sign up for our newsletter today. South Africa is a study in contrasts.

Gilead Sciences, the maker of a twice-a year anti-HIV injection, has approached South Africa’s medicine regulator to discuss how to get the shot registered locally as fast as possible in the country.

In today’s newsletter, Mia Malan tells us why the US isn’t giving SA LEN. Sign up for our newsletter today. By shutting South Africa out of its overseas funding for the roll-out of the revolutionary ...

In today’s newsletter, Linda Pretorius asks “who should get what slice of the LEN pie”? Sign up for our newsletter today. What’s the best way to divvy up a shipment of medicine that will cover less ...